This inventor holds 1 USPTO granted patent. Top assignees: Hiroshima University, Japan Science and Technology Agency, Two Cells Co., Ltd.. Active years: 2011.
Company Filing History:



Years Active: 2011
Title: Ryoko Kawabata: Innovator in Antifungal Peptide Research
Introduction
Ryoko Kawabata is a notable inventor based in Hiroshima, Japan. She has made significant contributions to the field of antifungal research through her innovative work on peptides. Her research aims to provide effective solutions for patients with impaired organ function, ensuring that they can receive treatment without adverse side effects.
Latest Patents
Kawabata holds a patent for "Peptides and compositions for inhibiting fungal growth." This patent introduces a novel peptide designed to exert a higher antifungal effect, particularly in patients whose organ functions are compromised. The peptide comprises several specific amino acid sequences, including:
(1) SEQ ID NO:1: Lys-Arg-Leu-Phe-Arg-Arg-Trp-Gln-Trp-Arg-Tyr,
(2) SEQ ID NO:2: Arg-Arg-Trp-Gln-Trp-Arg-Met-Lys-Lys-Tyr,
(3) SEQ ID NO:3: Lys-Arg-Trp-Gln-TTp-Arg-Leu-Tyr,
(4) SEQ ID NO:4: Lys-Arg-Leu-Phe-Lys-Tyr.
The patent also covers an antifungal agent comprising the peptide, a composition with fungicidal and growth inhibitory actions against fungi, and a medical apparatus that utilizes the peptide for its fungicidal properties.
Career Highlights
Throughout her career, Ryoko Kawabata has worked with esteemed institutions such as the Japan Science and Technology Agency and Hiroshima University. Her research has focused on developing innovative solutions to combat fungal infections, contributing to advancements in medical treatments.
Collaborations
Kawabata has collaborated with notable colleagues, including Hiroki Nikawa and Nobue Hiromoto. These partnerships have enhanced her research efforts and expanded the impact of her work in the scientific community.
Conclusion
Ryoko Kawabata's contributions to antifungal peptide research highlight her dedication to improving patient care through innovative solutions. Her patented work represents a significant advancement in the field, showcasing the potential of peptides in medical applications.